Beckman Coulter inks deal with Illumina for NGS library prep

By staff writers

February 22, 2022 -- Beckman Coulter Life Sciences has signed an agreement with Illumina to access that company's next-generation sequencing (NGS) technology to incorporate into its Biomek NGeniuS library preparation system, scheduled to launch later this year.

NGeniuS is a liquid handler designed for NGS library preparation, designed to automate tasks associated with the labor-intensive process of NGS library construction. It includes features like a reagent input carousel that minimizes the manual transfer of reagents, as well as an integrated thermal cycler and labware transport system.

Beckman Coulter has been pursuing relationships with chemistry companies to develop applications for NGeniuS. Under the new collaboration, Illumina will develop applications for the system that will be available to NGeniuS users through an electronic application library.

NGeniuS is scheduled to launch in the second quarter of 2022, according to Beckman Coulter.

Illumina to collaborate with Japan's National Cancer Center
Illumina and Japan's National Cancer Center have announced a collaboration that will use Illumina's DNA sequencing assay TruSight Oncology 500 ctDNA to...
Beckman Coulter launches DxU Iris urinalysis system at AACC
Beckman Coulter aims to improve laboratory workflow for processing urinalysis samples with a new automated diagnostic system, DxU Iris, introduced at...
Illumina, Merck partner on HRD test
Illumina and Merck have agreed to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency...
Beckman Coulter launches new COVID-19 IgG test
Beckman Coulter announced it has launched its Access SARS-CoV-2 immunoglobulin G (IgG) test, a fully quantitative, lab-based, IgG serology test that...
Beckman Coulter unveils new tabletop hematology analyzer
Beckman Coulter has introduced the DxH 560 AL, a tabletop hematology analyzer targeted at small and medium-sized labs.

Copyright © 2022

Last Updated ls 2/22/2022 9:55:00 AM